These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

435 related items for PubMed ID: 20233885

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. HPV-16 infection predicts treatment outcome in oropharyngeal squamous cell carcinoma.
    Nichols AC, Faquin WC, Westra WH, Mroz EA, Begum S, Clark JR, Rocco JW.
    Otolaryngol Head Neck Surg; 2009 Feb; 140(2):228-34. PubMed ID: 19201294
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Prognostic factors and survival unique to surgically treated p16+ oropharyngeal cancer.
    Haughey BH, Sinha P.
    Laryngoscope; 2012 Sep; 122 Suppl 2():S13-33. PubMed ID: 22926949
    [Abstract] [Full Text] [Related]

  • 5. Prognostic value of apoptosis-regulating protein expression in anal squamous cell carcinoma.
    Allal AS, Waelchli L, Bründler MA.
    Clin Cancer Res; 2003 Dec 15; 9(17):6489-96. PubMed ID: 14695153
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Predictive and prognostic markers in a series of patients with head and neck squamous cell invasive carcinoma treated with concurrent chemoradiation therapy.
    Gasparini G, Bevilacqua P, Bonoldi E, Testolin A, Galassi A, Verderio P, Boracchi P, Guglielmi RB, Pezzella F.
    Clin Cancer Res; 1995 Nov 15; 1(11):1375-83. PubMed ID: 9815934
    [Abstract] [Full Text] [Related]

  • 9. HPV-associated neuroendocrine carcinoma of the oropharynx: a rare new entity with potentially aggressive clinical behavior.
    Kraft S, Faquin WC, Krane JF.
    Am J Surg Pathol; 2012 Mar 15; 36(3):321-30. PubMed ID: 22301491
    [Abstract] [Full Text] [Related]

  • 10. Genetic signatures of HPV-related and unrelated oropharyngeal carcinoma and their prognostic implications.
    Klussmann JP, Mooren JJ, Lehnen M, Claessen SM, Stenner M, Huebbers CU, Weissenborn SJ, Wedemeyer I, Preuss SF, Straetmans JM, Manni JJ, Hopman AH, Speel EJ.
    Clin Cancer Res; 2009 Mar 01; 15(5):1779-86. PubMed ID: 19223504
    [Abstract] [Full Text] [Related]

  • 11. Defining molecular phenotypes of human papillomavirus-associated oropharyngeal squamous cell carcinoma: validation of three-class hypothesis.
    Weinberger PM, Yu Z, Kountourakis P, Sasaki C, Haffty BG, Kowalski D, Merkley MA, Rimm DL, Camp RL, Psyrri A.
    Otolaryngol Head Neck Surg; 2009 Sep 01; 141(3):382-9. PubMed ID: 19716018
    [Abstract] [Full Text] [Related]

  • 12. Predictors of response to chemo-radiotherapy and radiotherapy for esophageal squamous cell carcinoma.
    Miyazaki T, Kato H, Faried A, Sohda M, Nakajima M, Fukai Y, Masuda N, Manda R, Fukuchi M, Ojima H, Tsukada K, Kuwano H.
    Anticancer Res; 2005 Sep 01; 25(4):2749-55. PubMed ID: 16080521
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effect of human papillomavirus on patterns of distant metastatic failure in oropharyngeal squamous cell carcinoma treated with chemoradiotherapy.
    Trosman SJ, Koyfman SA, Ward MC, Al-Khudari S, Nwizu T, Greskovich JF, Lamarre ED, Scharpf J, Khan MJ, Lorenz RR, Adelstein DJ, Burkey BB.
    JAMA Otolaryngol Head Neck Surg; 2015 May 01; 141(5):457-62. PubMed ID: 25742025
    [Abstract] [Full Text] [Related]

  • 16. Cancer stem cell enrichment marker CD98: a prognostic factor for survival in patients with human papillomavirus-positive oropharyngeal cancer.
    Rietbergen MM, Martens-de Kemp SR, Bloemena E, Witte BI, Brink A, Baatenburg de Jong RJ, Leemans CR, Braakhuis BJ, Brakenhoff RH.
    Eur J Cancer; 2014 Mar 01; 50(4):765-73. PubMed ID: 24315751
    [Abstract] [Full Text] [Related]

  • 17. Molecular classification identifies a subset of human papillomavirus--associated oropharyngeal cancers with favorable prognosis.
    Weinberger PM, Yu Z, Haffty BG, Kowalski D, Harigopal M, Brandsma J, Sasaki C, Joe J, Camp RL, Rimm DL, Psyrri A.
    J Clin Oncol; 2006 Feb 10; 24(5):736-47. PubMed ID: 16401683
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Impact of viral E2-gene status on outcome after radiotherapy for patients with human papillomavirus 16-positive cancer of the uterine cervix.
    Lindel K, de Villiers EM, Burri P, Studer U, Altermatt HJ, Greiner RH, Gruber G.
    Int J Radiat Oncol Biol Phys; 2006 Jul 01; 65(3):760-5. PubMed ID: 16682151
    [Abstract] [Full Text] [Related]

  • 20. Cyclin A as a predictive factor for chemotherapy response in advanced head and neck cancer.
    Rodriguez-Pinilla M, Rodriguez-Peralto JL, Hitt R, Sanchez JJ, Ballestin C, Diez A, Sanchez-Verde L, Alameda F, Sanchez-Cespedes M.
    Clin Cancer Res; 2004 Dec 15; 10(24):8486-92. PubMed ID: 15623629
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.